Silq Technologies Corporation was spun out of the University of California, Los Angeles with the vision to commercialize technology originally conceived in the Department of Chemistry and Biochemistry. The technology is a coating formulation that permanently transforms the surfaces of plastics and elastomers to confer highly desirable properties such as hydrophilicity, enhanced lubricity and resistance to biofilm formation. The developers of the formulation, Professor Richard Kaner and Dr. Brian McVerry, are co-founders of the company and are members of its Board, with Dr. McVerry also serving as Chief Technology Officer. Early research at UCLA was funded by grants from the National Science Foundation and UCLA’s Physical Sciences Entrepreneurship and Innovation Fund. Subsequently, Dr. Jack Kavanaugh, a successful LA-based medical devices and biosciences entrepreneur, joined the effort and raised the capital needed for the company to further its business objectives. Silq secured FDA clearance to market indwelling Foley catheters coated with its formulation in April 2020 and is currently pursuing additional opportunities for its proprietary chemistry in the medical, industrial and retail sectors. The company is based in Los Angeles, CA.